Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
Condition(s):Proteinuria; Hypertension; Type II DiabetesLast Updated:May 11, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Proteinuria; Hypertension; Type II DiabetesLast Updated:May 11, 2018Terminated
Condition(s):Coronary Heart DiseaseLast Updated:June 11, 2012Completed
Condition(s):Cystic FibrosisLast Updated:January 10, 2006Completed
Condition(s):Insulin ResistanceLast Updated:August 24, 2010Completed
Condition(s):HypertensionLast Updated:March 28, 2012Completed
Condition(s):HypertensionLast Updated:November 1, 2006Completed
Condition(s):Gastroesophageal Reflux Disease; HeartburnLast Updated:September 20, 2012Completed
Condition(s):Essential HypertensionLast Updated:August 20, 2015Completed
Condition(s):Kidney Transplant; ComplicationsLast Updated:December 27, 2022Completed
Condition(s):Diabetic Nephropathies; HypertensionLast Updated:October 16, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.